Quantification of Fragments of Human Serum Inter-α-Trypsin Inhibitor Heavy Chain 4 by a Surface-Enhanced Laser Desorption/Ionization-Based Immunoassay | Zendy

Jin Song | Zendy; Manisha J. Patel | Zendy; C. Nicole Rosenzweig | Zendy; Yee ChanLi | Zendy; Lori J. Sokoll | Zendy; Eric T. Fung | Zendy; Nam-Ho Choi-Miura | Zendy; Michael Goggins | Zendy; Daniel W. Chan | Zendy; Zhen Zhang | Zendy

Open Access

Quantification of Fragments of Human Serum Inter-α-Trypsin Inhibitor Heavy Chain 4 by a Surface-Enhanced Laser Desorption/Ionization-Based Immunoassay

Author(s) -

Jin Song,

Manisha J. Patel,

C. Nicole Rosenzweig,

Yee ChanLi,

Lori J. Sokoll,

Eric T. Fung,

Nam-Ho Choi-Miura,

Michael Goggins,

Daniel W. Chan,

Zhen Zhang

Publication year - 2006

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2005.065722

Subject(s) - fragmentation (computing) , immunoassay , chemistry , ex vivo , trypsin , matrix assisted laser desorption/ionization , antibody , microbiology and biotechnology , biology , biochemistry , desorption , immunology , in vitro , enzyme , ecology , organic chemistry , adsorption

Several proteolytically derived fragments from the proline-rich region (PRR) of human inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) have been identified by surface-enhanced or matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS or MALDI-TOF-MS) as potential disease markers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research